Literature DB >> 16098274

Risperidone for irritable aggression in posttraumatic stress disorder.

Dan J Stein1, Paul D Carey, Soraya Seedat, Jonathan Ipser.   

Abstract

Entities:  

Year:  2005        PMID： 16098274

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  9 in total

Review 1.  Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress.

Authors:  Dennis S Charney
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

2.  Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.

Authors:  M I Butterfield; M E Becker; K M Connor; S Sutherland; L E Churchill; J R Davidson
Journal:  Int Clin Psychopharmacol       Date:  2001-07       Impact factor: 1.659

3.  A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.

Authors:  C J McDougle; C N Epperson; G H Pelton; S Wasylink; L H Price
Journal:  Arch Gen Psychiatry       Date:  2000-08

Review 4.  Linking posttraumatic stress disorder and psychosis: a look at epidemiology, phenomenology, and treatment.

Authors:  Soraya Seedat; Murray B Stein; Piet P Oosthuizen; Robin A Emsley; Dan J Stein
Journal:  J Nerv Ment Dis       Date:  2003-10       Impact factor: 2.254

5.  Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.

Authors:  Soraya Seedat; Murray B Stein
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

6.  Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms.

Authors:  M B Hamner; R A Faldowski; H G Ulmer; B C Frueh; M G Huber; G W Arana
Journal:  Int Clin Psychopharmacol       Date:  2003-01       Impact factor: 1.659

Review 7.  World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.

Authors:  Borwin Bandelow; Josef Zohar; Eric Hollander; Siegfried Kasper; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2002-10       Impact factor: 4.132

8.  Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.

Authors:  Murray B Stein; Neal A Kline; Jeffrey L Matloff
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

Review 9.  DARPP-32: an integrator of neurotransmission.

Authors:  Per Svenningsson; Akinori Nishi; Gilberto Fisone; Jean-Antoine Girault; Angus C Nairn; Paul Greengard
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.